UPDATE : Monday, September 7, 2020
상단여백
Shire Korea improves its hemophilia B treatment
Shire Korea has improved the function of its Hemophilia B treatment, Rixubi...
by Constance Williams  |  2017-07-03 14:07
라인
Siemens Healthcare Korea elects new president
Siemens Healthcare Korea has appointed Lee Myung-gyun이명균 as its new preside...
by Constance Williams  |  2017-07-03 14:04
라인
Medical community opposes controls on certificate issuing fees
A controversy is arising over the government's decision to set a ceilin...
by Song Soo-youn / Kwak Sung-sun  |  2017-07-03 12:19
라인
Experts call for more transparent operation of medical insurers
Private insurance companies make requests for “medical advice” related to i...
by Lee Min-ju  |  2017-06-30 18:40
라인
Michael Porter: Change existing healthcare with ‘value-based’ one
The rising cost of health care is a global issue, and Michael Porter aims t...
by Marian Chu  |  2017-06-30 18:08
라인
Janssen director points out flaws in Korean quality systems
“We need to provide a gap in quality systems and quality management for vac...
by Constance Williams  |  2017-06-30 17:09
라인
Yonsei Cancer Center emerges as model of hospitalist surgical ward
A pilot program to introduce the hospitalist system is making slow progress...
by Choi Gwang-seok  |  2017-06-30 16:32
라인
Health industry export exceeds $10 billion for 1st time last year
Korea’s export of medicines and medical equipment exceeded $10 billion for ...
by Kwak Sung-sun  |  2017-06-30 14:11
라인
IVI, KOHI to cooperate in global education
The International Vaccine Institute (IVI) and Korea Human Resource Developm...
by Constance Williams  |  2017-06-30 11:25
라인
Tissue donation remains alien concept for many Koreans
Out of all tissue donations in Korea, only 26 percent are domestically proc...
by Marian Chu  |  2017-06-30 10:59
라인
Hepatitis C treatment data presented at ‘Liver Week 2017’
Korea BMS Pharma (CEO: Park Hye-sun) presented their research of genotype 1...
by Constance Williams  |  2017-06-30 10:51
라인
Celltrion applies for FDA approval of anticancer biosimilar
The U.S. Food and Drug Administration (FDA) has accepted Celltrion’s applic...
by Constance Williams  |  2017-06-29 18:03
라인
Pfizer executive discusses social responsibility on insurance treatments
Michael Goettler, the global president of rare disease business at Pfizer, ...
by Constance Williams  |  2017-06-29 16:42
라인
[Column]‘BIO 2017’ revealed Korean government’s absence of policy
I attended the “2017 BIO International Convention” held in San Diego, Calif...
by Song Hyoung-gon  |  2017-06-29 15:38
라인
Insurance assessors will use AI to ferret out irregular claims
Health Insurance Review and Assessment Service (HIRA)건강보험심사평가원 will push fo...
by Yang Geum-deok  |  2017-06-29 13:24
라인
Marydoty Hospital leaves Korea fulfilling 35 years of service mission
The Marydoty Hospital completed its medical treatments in Korea with the la...
by Kwak Sung-sun  |  2017-06-29 11:20
라인
David and Goliath; how Korean pharmaceuticals should compete with multinational giants
When foreign experts look at the Korean pharmaceutical industry, they wonde...
by Marian Chu  |  2017-06-29 09:44
라인
Korean, US firms tie up to bring in Alzheimer treatment
DuchemBio Co. (CEO: Kim Jong-woo), the first Korean company that produced d...
by Constance Williams  |  2017-06-28 17:51
라인
Medytox’s overseas exchange program helps global advances
Medytox Inc. (CEO Jung Hyun-ho), Korea's largest maker of botulinum tox...
by Constance Williams  |  2017-06-28 16:43
라인
‘Global Bio Conference 2017’ opens for 3-day run at COEX
The “Global Bio Conference 2017 (GBC 2017)” kicked off its annual conferenc...
by Marian Chu  |  2017-06-28 16:30
여백
여백
여백
Back to Top